drugset / Trial / NCT00920270

Nebulized Colistin for Hospital-Acquired Pneumonia

NCT00920270

Phase 3 Unknown 140 enrolled Mahidol University
RandomizedParallel-groupOpen-labelTreatment

Summary

Nebulized Colistin for Adjunctive Therapy of Hospital-Acquired Pneumonia caused by Gram Negative Bacteria should be more effective than conventional therapy

Timeline

Start
2006-06
Primary completion
2010-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Colistin Other / unclassified 75 mg Other

Indications